Correlation Engine 2.0
Clear Search sequence regions


Aspirin is widely used as an anti-inflammatory, anti-platelet, anti-pyretic, and cancer-preventive agent; however, the molecular mode of action is unlikely due entirely to the inhibition of cyclooxygenases. Here, we report the agonist activity of several aspirin metabolites at GPR35, a poorly characterized orphan G protein-coupled receptor. 2,3,5-Trihydroxybenzoic acid, an aspirin catabolite, was found to be the most potent GPR35 agonist among aspirin metabolites. Salicyluric acid, the main metabolite of aspirin, was also active. These results suggest that the GPR35 agonist activity of certain aspirin metabolites may contribute to the clinical features of aspirin.

Citation

Huayun Deng, Ye Fang. Aspirin metabolites are GPR35 agonists. Naunyn-Schmiedeberg's archives of pharmacology. 2012 Jul;385(7):729-37

Expand section icon Mesh Tags

Expand section icon Substances


PMID: 22526472

View Full Text